However, it was shown that inhibition of IL-6 trans-signalling by the administration of recombinant sgp130Fc reduced cholangiocarcinoma cell line viability and induced apoptosis, whereas both migration and proliferation increased [157]. The gene discussed is IL6; the disease is cholangiocarcinoma.